Comparison of Integrin αvβ3 Expression and Glucose Metabolism in Primary and Metastatic Lesions in Cancer Patients: A PET Study Using 18F-Galacto-RGD and 18F-FDG-Reference-Cited by-同舟云学术

Comparison of Integrin αvβ3 Expression and Glucose Metabolism in Primary and Metastatic Lesions in Cancer Patients: A PET Study Using 18F-Galacto-RGD and 18F-FDG

Published:2007-12-12 Issue:1 Volume:49 Page:22-29
ISSN:0161-5505
Container-title:Journal of Nuclear Medicine
language:en
Short-container-title:J Nucl Med

Author:

Beer Ambros J.,Lorenzen Sylvie,Metz Stephan,Herrmann Ken,Watzlowik Petra,Wester Hans-Jürgen,Peschel Christian,Lordick Florian,Schwaiger Markus

Publisher

Society of Nuclear Medicine

Subject

Radiology Nuclear Medicine and imaging

Reference40 articles.

1. Spotlight on Bevacizumab in Advanced Colorectal Cancer, Breast Cancer, and Non-Small Cell Lung Cancer1

2. Tyrosine Kinase Inhibitors of Vascular Endothelial Growth Factor Receptors in Clinical Trials: Current Status and Future Directions

3. Phase II Evaluations of Cilengitide in Asymptomatic Patients with Androgen-Independent Prostate Cancer: Scientific Rationale and Study Design

4. A randomized multi-center phase II trial of the angiogenesis inhibitor Cilengitide (EMD 121974) and gemcitabine compared with gemcitabine alone in advanced unresectable pancreatic cancer

Cited by 161 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. New PET Tracers for Lymphoma;PET Clinics;2024-10

2. The application of 18F-FDG PET/CT imaging for human hepatocellular carcinoma: a narrative review;Quantitative Imaging in Medicine and Surgery;2023-09

3. Radionuclide-based theranostics — a promising strategy for lung cancer;European Journal of Nuclear Medicine and Molecular Imaging;2023-03-16

4. Comparison of integrin αvβ3 expression with 68Ga-NODAGA-RGD PET/CT and glucose metabolism with 18F-FDG PET/CT in esophageal or gastroesophageal junction cancers;European Journal of Hybrid Imaging;2023-02-01

5. Molecular Imaging in Oncology;Molecular Imaging and Targeted Therapy;2023